139 related articles for article (PubMed ID: 11525808)
61. IgG anti-Galnac-GD1a antibodies bind to neuromuscular junctions of rat hemidiaphragm.
Nagaoka T; Hotta S; Chiba T; Utsunomiya I; Abe K; Yoshino H; Koshikawa C; Taguchi K
Muscle Nerve; 2012 Nov; 46(5):705-10. PubMed ID: 23055311
[TBL] [Abstract][Full Text] [Related]
62. [Clinical factors relating to the presence of serum anti-GM1 and GD1b antibodies in demyelinating neuropathy--study using a multivariate analysis].
Irie S; Saito T; Kanazawa N; Ito H; Kowa H
Rinsho Shinkeigaku; 1994 May; 34(5):454-60. PubMed ID: 7924057
[TBL] [Abstract][Full Text] [Related]
63. The 301 to 314 amino acid residue of beta-tubulin is not a target epitope for serum IgM antibodies in chronic inflammatory demyelinating polyneuropathy.
Tagawa Y; Yuki N; Hirata K
J Neurol Sci; 1999 Feb; 163(1):44-6. PubMed ID: 10223409
[TBL] [Abstract][Full Text] [Related]
64. Mapping immunoreactive epitopes in the human peripheral nervous system using human monoclonal anti-GM1 ganglioside antibodies.
O'Hanlon GM; Paterson GJ; Veitch J; Wilson G; Willison HJ
Acta Neuropathol; 1998 Jun; 95(6):605-16. PubMed ID: 9650753
[TBL] [Abstract][Full Text] [Related]
65. Autoantibodies to peripheral nerve glycosphingolipids SPG, SLPG, and SGPG in Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy.
Yuki N; Tagawa Y; Handa S
J Neuroimmunol; 1996 Oct; 70(1):1-6. PubMed ID: 8862128
[TBL] [Abstract][Full Text] [Related]
66. Characterization of IgG and IgM antibodies induced in melanoma patients by immunization with purified GM2 ganglioside.
Livingston PO; Ritter G; Srivastava P; Padavan M; Calves MJ; Oettgen HF; Old LJ
Cancer Res; 1989 Dec; 49(24 Pt 1):7045-50. PubMed ID: 2582446
[TBL] [Abstract][Full Text] [Related]
67. Effect of low power 655 nm diode laser irradiation on the neuromuscular junctions of the mouse diaphragm.
Nicolau RA; Martinez MS; Rigau J; Tomàs J
Lasers Surg Med; 2004; 34(3):277-84. PubMed ID: 15022258
[TBL] [Abstract][Full Text] [Related]
68. Antiganglioside antibody in patients with Guillain-Barré syndrome who show bulbar palsy as an initial symptom.
Koga M; Yuki N; Hirata K
J Neurol Neurosurg Psychiatry; 1999 Apr; 66(4):513-6. PubMed ID: 10201426
[TBL] [Abstract][Full Text] [Related]
69. Changes in MEPP and EPP amplitude distributions in the mouse diaphragm during synapse formation and degeneration.
Muniak CG; Kriebel ME; Carlson CG
Brain Res; 1982 Oct; 281(2):123-38. PubMed ID: 7139344
[TBL] [Abstract][Full Text] [Related]
70. Anti-GQ1b antibodies and evoked acetylcholine release at mouse motor endplates.
Bullens RW; O'Hanlon GM; Goodyear CS; Molenaar PC; Conner J; Willison HJ; Plomp JJ
Muscle Nerve; 2000 Jul; 23(7):1035-43. PubMed ID: 10882997
[TBL] [Abstract][Full Text] [Related]
71. Localization of major gangliosides in the PNS: implications for immune neuropathies.
Gong Y; Tagawa Y; Lunn MP; Laroy W; Heffer-Lauc M; Li CY; Griffin JW; Schnaar RL; Sheikh KA
Brain; 2002 Nov; 125(Pt 11):2491-506. PubMed ID: 12390975
[TBL] [Abstract][Full Text] [Related]
72. The role of sialic acid in the nerve terminal for the release of transmitter.
Nishimura M; Kozaki S; Sakaguchi G; Yagasaki O; Yanagiya I
Life Sci; 1984 Dec; 35(24):2435-41. PubMed ID: 6151109
[TBL] [Abstract][Full Text] [Related]
73. High-affinity anti-ganglioside IgG antibodies raised in complex ganglioside knockout mice: reexamination of GD1a immunolocalization.
Lunn MP; Johnson LA; Fromholt SE; Itonori S; Huang J; Vyas AA; Hildreth JE; Griffin JW; Schnaar RL; Sheikh KA
J Neurochem; 2000 Jul; 75(1):404-12. PubMed ID: 10854286
[TBL] [Abstract][Full Text] [Related]
74. Molecular mimicry in chronic inflammatory demyelinating polyneuropathy and melanoma.
Weiss MD; Luciano CA; Semino-Mora C; Dalakas MC; Quarles RH
Neurology; 1998 Dec; 51(6):1738-41. PubMed ID: 9855537
[TBL] [Abstract][Full Text] [Related]
75. Prospective study on anti-ganglioside antibodies in childhood Guillain-Barré syndrome.
Schessl J; Koga M; Funakoshi K; Kirschner J; Muellges W; Weishaupt A; Gold R; Korinthenberg R
Arch Dis Child; 2007 Jan; 92(1):48-52. PubMed ID: 16920757
[TBL] [Abstract][Full Text] [Related]
76. Complex of GM1- and GD1a-like lipo-oligosaccharide mimics GM1b, inducing anti-GM1b antibodies.
Koga M; Gilbert M; Li J; Yuki N
PLoS One; 2015; 10(4):e0124004. PubMed ID: 25867522
[TBL] [Abstract][Full Text] [Related]
77. Guillain-Barré syndrome with antibody to a ganglioside, N-acetylgalactosaminyl GD1a.
Kaida K; Kusunoki S; Kamakura K; Motoyoshi K; Kanazawa I
Brain; 2000 Jan; 123 ( Pt 1)():116-24. PubMed ID: 10611126
[TBL] [Abstract][Full Text] [Related]
78. Rapidly progressive, predominantly motor Guillain-Barré syndrome with anti-GalNAc-GD1a antibodies.
Ang CW; Yuki N; Jacobs BC; Koga M; Van Doorn PA; Schmitz PI; Van Der Meché FG
Neurology; 1999 Dec; 53(9):2122-7. PubMed ID: 10599792
[TBL] [Abstract][Full Text] [Related]
79. Temporal profile of anti-ganglioside antibodies and their relation to clinical parameters and treatment in Guillain-Barré syndrome.
Press R; Matá S; Lolli F; Zhu J; Andersson T; Link H
J Neurol Sci; 2001 Sep; 190(1-2):41-7. PubMed ID: 11574105
[TBL] [Abstract][Full Text] [Related]
80. Precursor-product relationship between GM1 and GD1a biosynthesized from exogenous GM2 ganglioside in rat liver.
Trinchera M; Ghidoni R
J Biochem; 1990 Apr; 107(4):619-23. PubMed ID: 2358435
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
